Empresa Novartis CBOE EUROPE EQUITIES

Empresa Novartis CBOE EUROPE EQUITIES

0QLR

CH0012005267

Farmacéuticos

Acciones

0QLR

CH0012005267

Farmacéuticos

Resumen de negocios

Ventas por actividad

Ventas por región

Directores

Administradores

Clase de acciones

Accionistas

Participaciones

Información de la empresa

Empresas del grupo

Sector

Ventas por actividad

Ventas por región

Sector Farmacéuticos - Otros

Resumen de negocios

Ventas por actividad

Ventas por región

Directores

Administradores

Clase de acciones

Accionistas

Participaciones

Información de la empresa

Empresas del grupo

Sector

Ventas por actividad

Ventas por región

Sector Farmacéuticos - Otros

Instrumento Inactivo

Precio de cierre CBOE EUROPE EQUITIES Otros sitios de cotización
- ^EUR	-

14/06	El regulador de la UE obliga a actualizar las etiquetas de las terapias CAR-T contra el cáncer	RE
14/06	Bolsa de Madrid: Los ganadores se lo llevan todo

Novartis AG es uno de los líderes mundiales en el diseño, fabricación y comercialización de productos farmacéuticos. Las ventas netas (excluidas las actividades interrumpidas) se desglosan por áreas terapéuticas de la siguiente manera
- oncología (29,9%);
- inmunología (17,2%)
- enfermedades cardiovasculares, renales y metabólicas (14,1%)
- neurociencia (8,9%).
El resto de las ventas netas (29,9%) procede de la fabricación por contrato de productos farmacéuticos.
A finales de 2023, Novartis AG contaba con 33 centros de producción en todo el mundo.
Las ventas netas se distribuyen geográficamente de la siguiente manera: Europa (33%), Estados Unidos (39,5%), Asia/África/Australasia (20,5%), Canadá y Latinoamérica (7%).

CHF en millones	2022	Peso	2023	Peso	Delta
Established Brands 30,0 %	-	-	12 238	30,0 %	-
Oncology 29,9 %	-	-	12 213	29,9 %	-
Immunology 17,2 %	-	-	7 008	17,2 %	-
Cardiovascular, Renal and Metabolic 14,1 %	-	-	5 743	14,1 %	-
Neuroscience 8,9 %	-	-	3 633	8,9 %	-

CHF en millones	2022	Peso	2023	Peso	Delta
United States 39,5 %	16 860	34,9 %	16 139	39,5 %	-4,28 %
Europe 18,9 %	10 469	21,7 %	7 704	18,9 %	-26,41 %
Asia/Africa/Australasia 9,1 %	4 975	10,3 %	3 700	9,1 %	-25,63 %
Germany 7,4 %	4 086	8,5 %	3 026	7,4 %	-25,94 %
China 7,2 %	2 987	6,2 %	2 936	7,2 %	-1,73 %
Canada and Latin America 7,0 %	3 709	7,7 %	2 854	7,0 %	-23,04 %
Japan 4,2 %	2 106	4,4 %	1 729	4,2 %	-17,90 %
France 3,8 %	2 156	4,5 %	1 572	3,8 %	-27,09 %
Switzerland 2,9 %	926	1,9 %	1 175	2,9 %	+26,88 %

Directores	Puesto	Edad	Desde
Vasant Narasimhan CEO	Chief Executive Officer	48	01/01/05
Harry Werner Kirsch DFI	Director of Finance/CFO	59	01/01/03
Shreeram Aradhye CTO	Chief Tech/Sci/R&D Officer	62	16/05/22
Steffen Lang COO	Chief Operating Officer	57	01/04/17
Klaus Moosmayer CMP	Compliance Officer	56	01/12/18
Samir Shah IRO	Public Communications Contact	63	01/01/04
Simon Brown PRN	Corporate Officer/Principal	-	01/08/13
Kees Roks AUD	Comptroller/Controller/Auditor	61	01/05/22
Linda Kanitra PRN	Corporate Officer/Principal	-	-
Robert Kowalski HRO	Human Resources Officer	56	01/09/21

Administradores	Puesto	Edad	Desde
Bill Winters BRD	Director/Board Member	62	01/01/13
Simon Moroney BRD	Director/Board Member	65	28/02/20
Hans Jörg Reinhardt CHM	Chairman	68	01/01/13
John Young BRD	Director/Board Member	60	07/03/23
Bridgette Heller BRD	Director/Board Member	62	28/02/20
Ton Büchner BRD	Director/Board Member	59	01/01/16
Charles Sawyers BRD	Director/Board Member	65	01/01/13
Nancy Andrews BRD	Director/Board Member	65	01/01/15
Patrice Bula BRD	Director/Board Member	68	28/02/19
Frans van Houten BRD	Director/Board Member	64	28/02/17

	Vote	Quantity	Flotante	Autocontrol	Total Float
Acción A	1	2 189 930 497	1 866 336 959 ( 85,22 %)	233 443 766 ( 10,66 %)	85,22 %

Nombre	Acciones	%	Valoración
NOVARTIS AG 6,625 %	145 083 991	6,625 %	14 984 M €
Sandoz Family Foundation 4,070 %	89 135 960	4,070 %	9 206 M €
UBS Asset Management Switzerland AG 3,123 %	68 391 910	3,123 %	7 063 M €
MFS International Singapore Pte Ltd. 0,1785 %	3 909 515	0,1785 %	404 M €
MFS International (UK) Ltd. 0,1768 %	3 870 948	0,1768 %	400 M €
State Street Global Advisors Ltd. 0,1652 %	3 617 087	0,1652 %	374 M €
Sjunde AP-fonden 0,1384 %	3 031 826	0,1384 %	313 M €
Eleva Capital LLP 0,1355 %	2 967 691	0,1355 %	306 M €
Barings (UK) Ltd. 0,1310 %	2 868 212	0,1310 %	296 M €
Amundi Asset Management SA (Investment Management) 0,1087 %	2 379 602	0,1087 %	246 M €

Nombre	Acciones	%	Valoración
PRIMECAP Management Co. 0,5670 %	12 417 755	0,5670 %	1 281 M €
Dodge & Cox 0,5641 %	12 353 985	0,5641 %	1 274 M €
Eaton Vance Management 0,3314 %	7 258 381	0,3314 %	749 M €
Dimensional Fund Advisors LP 0,2748 %	6 018 082	0,2748 %	621 M €
Loomis, Sayles & Co. LP 0,2702 %	5 917 972	0,2702 %	610 M €
Fiduciary Trust Company International 0,2603 %	5 700 550	0,2603 %	588 M €
U.S. Trust Company of Delaware 0,2273 %	4 977 839	0,2273 %	513 M €
Wellington Management Co. LLP 0,2096 %	4 589 350	0,2096 %	473 M €
Wells Fargo Bank NA 0,1826 %	3 997 877	0,1826 %	412 M €
The Ayco Co. LP 0,1397 %	3 059 361	0,1397 %	316 M €

Nombre	Acciones	%	Valoración
LUKB Expert Fondsleitung AG -	64 694	-	7 M €
Swiss Rock Asset Management AG -	19 614	-	2 M €

Nombre	Acciones	%	Valoración
NOVARTIS AG 6.63%	145 083 991	6.63%	14 983 623 163 $
MORPHOSYS AG 51.00%	19 235 376	51.00%	1 433 544 095 $
SANDOZ GROUP AG 2.99%	12 886 900	2.99%	457 966 018 $
NOVARTIS INDIA LIMITED 70.68%	17 450 680	70.68%	218 239 949 $
THIRD HARMONIC BIO, INC. 6.45%	2 642 762	6.45%	35 175 162 $
ERASCA, INC. 4.74%	12 307 692	4.74%	31 015 384 $
OCULIS HOLDING AG 4.66%	1 713 521	4.66%	20 151 007 $
MOLECULAR PARTNERS AG 4.74%	1 739 130	4.74%	6 554 381 $
PRECISION BIOSCIENCES, INC. 5.97%	413 581	5.97%	5 335 195 $

Novartis AG

Lichtstrasse 35

4056, Basel

+41 61 324 1111

http://www.novartis.com

Nombre	Categoría y sector
Novartis Healthcare Pvt Ltd. Novartis Healthcare Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Healthcare Pvt Ltd. is an Indian company that manufactures and markets health care and nutritional products. The company is based in Mumbai, India. The company was founded in 1997. The CEO is Sanjay Prabhakar Murdeshwar.	Pharmaceuticals: Major
Novartis Services, Inc.
Novartis International AG Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.	Pharmaceuticals: Major
Novartis Pharma AG Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.	Pharmaceuticals: Major
Novartis Pharma GmbH Novartis Pharma GmbH Pharmaceuticals: MajorHealth Technology Novartis Pharma GmbH engages in the production and sale of pharmaceutical products. The firm establishes and operates institutes for the development of medicinal products. It also conducts research and development in the field of pharmacy. The company was founded by Johann Rudolf Geigy-Gemuseus in 1758 and is headquartered in Vienna, Austria.	Pharmaceuticals: Major
Sandoz GmbH Sandoz GmbH Pharmaceuticals: MajorHealth Technology Sandoz GmbH manufactures generic pharmaceuticals and biotechnological drugs. Its products includes bio-similars, inhalers, patches, injectables, and oral solids. The company was founded in 1946 and is headquartered in Kundl, Austria.	Pharmaceuticals: Major
Alcon Ophthalmika GmbH
EBEWE Pharma Ges.m.b.H. Nfg.KG EBEWE Pharma Ges.m.b.H. Nfg.KG Pharmaceuticals: MajorHealth Technology EBEWE Pharma Ges.m.b.H. Nfg.KG engages in the development and manufacture of injectable pharmaceutical specialties. The firm offers therapy solutions for colon, lung, breast, and prostate cancer. It also specializes in drug and pharmaceutical development, as well as preclinical studies. The company was founded in 1934 and is headquartered in Unterach am Attersee, Austria.	Pharmaceuticals: Major
NOVARTIS INDIA LIMITED	Pharmaceuticals: Major
Novartis UK Pension Scheme	Investment Managers
Novartis Investment Ltd.
Novartis Holding AG Novartis Holding AG Financial ConglomeratesFinance Part of Novartis AG, Novartis Holding AG is a Swiss healthcare company that provides solutions to address the evolving needs of patients worldwide. The company is based in Basel, Switzerland. Novartis Holding specializes in Managed Access Programs and is committed to the discovery, development, and marketing of innovative products to improve the well-being of all Canadians. The company prides itself on its commitment to diversity and to nurturing an inclusive and inspiring environment.	Financial Conglomerates
Novartis Finance SA	Finance/Rental/Leasing
Sandoz Pvt Ltd. Sandoz Pvt Ltd. Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz Pvt Ltd. is an Indian company that develops, manufactures and markets generic pharmaceutical products. The company is based in Mumbai, India and was founded in 1995.	Pharmaceuticals: Generic
Novartis BioVenturesAG Novartis BioVenturesAG Investment ManagersFinance Part of Novartis AG, Novartis BioVenturesAG is an alternative investment manager. The company is based in Basel, Switzerland.	Investment Managers
Novartis Investments SARL Novartis Investments SARL Financial ConglomeratesFinance Novartis Investments SARL is an investment holding company with interest in medicines and pharmaceuticals sector. The company was founded on July 05, 2002 and is headquartered in Luxembourg.	Financial Conglomerates
Novartis Securities Investment Ltd. Novartis Securities Investment Ltd. Investment ManagersFinance Part of Novartis AG, Novartis Securities Investment Ltd. is an investment bank that offers investment advice. The company is located in Bermuda.	Investment Managers
Novartis Capital Corp. Novartis Capital Corp. Finance/Rental/LeasingFinance Novartis Capital Corp. engages in the manufacture of pharmaceutical products. The company is headquartered in East Hanover, NJ.	Finance/Rental/Leasing
Novartis Investment Ltd. (2120)

	Varia. 1 de ene.	Capi.
ELI LILLY AND COMPANY	+52,40 %	791 mil M
NOVO NORDISK A/S	+40,45 %	630 mil M
MERCK & CO., INC.	+17,13 %	328 mil M
ABBVIE INC.	+9,24 %	298 mil M
ASTRAZENECA PLC	+17,25 %	246 mil M
ROCHE HOLDING AG	+0,41 %	225 mil M
AMGEN INC.	+4,49 %	160 mil M
PFIZER, INC.	-6,30 %	156 mil M
SANOFI	-2,33 %	116 mil M

Farmacéuticos - Otros

Farmacéutica e investigación médica

Farmacéuticos

Farmacéuticos

Farmacéuticos - Otros